Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: WebinarsShorts
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Erin Wallace

Advertisement

Articles by Erin Wallace

IP/IV Chemo Improves Overall Survival in Ovarian Cancer

ByErin Wallace
August 10th 2015

Maurie Markman urges patients with ovarian cancer who have undergone surgery to speak with their gynecologic oncologist and see if IP therapy is right for them.

Advertisement

Latest Updated Articles

  • IP/IV Chemo Improves Overall Survival in Ovarian Cancer
    IP/​IV Chemo Improves Overall Survival in Ovarian Cancer

    August 10th 2015



Advertisement
Advertisement

Trending on CURE

1

Why I Chose a Treatment Break After Years of Living With Stage 4 Ovarian Cancer

2

When the Scan Is Over but the Waiting Begins: Living With Lymphoma Scanxiety

3

Why I Don’t Want to Hear “You’ll Beat This” After a Metastatic Breast Cancer Diagnosis

4

Diagnosed at 25 With Hodgkin's Lymphoma, She Says This Saved Her Life

5

RASolute 302 and the Future of Pancreatic Cancer Treatment: Paul Oberstein, MD, on the KRAS Breakthrough

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.